1-3 of 3
Shannon L. Maude
Close
Sort by
Journal Articles

Evidence-Based Minireview: What is the role for HSCT or immunotherapy in pediatric hypodiploid B-cell acute lymphoblastic leukemia?

Evidence-Based Minireview
Aimee C. Talleur, Shannon L. Maude
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2020) 2020 (1): 508–511.
https://doi.org/10.1182/hematology.2020000162
Published: 2020
Journal Articles

CAR T cells vs allogeneic HSCT for poor-risk ALL

Caroline Diorio, Shannon L. Maude
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2020) 2020 (1): 501–507.
https://doi.org/10.1182/hematology.2020000172
Published: 2020
Journal Articles

Chimeric antigen receptor T-cell therapy for ALL

Shannon L. Maude, Elizabeth J. Shpall, Stephan A. Grupp
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 559–564.
https://doi.org/10.1182/asheducation-2014.1.559
Published: 2014